MICA and chronic myelogenous leukemia, BCR-ABL1 positive: CML cells may also evade NK cell attacks by altering surface antigens, such as down-regulating the expression of NKG2DL or MHC, to inhibit the action of NK cells by secreting soluble MICA (sMICA) and reduce NK cell recognition (198).